Changes

m
Line 16: Line 16:  
Overall, one clear theme emerged from the BBE: The need for national leadership, national standards, national approaches, and national transparency to help bring Canada up to the level of COI management seen in other countries.<ref name=":5" /> A report summarizing the BBE presentations and discussions is available in both official languages using the following links:
 
Overall, one clear theme emerged from the BBE: The need for national leadership, national standards, national approaches, and national transparency to help bring Canada up to the level of COI management seen in other countries.<ref name=":5" /> A report summarizing the BBE presentations and discussions is available in both official languages using the following links:
   −
[[Media:BBE COI in CPG development _EN_FINAL.pdf|CIHR/PHAC Best Brains Exchange (English) - Reducing and managing conflicts of interest in clinical practice guideline development: Do we need Pan-Canadian standards?]]
+
[[Images/0/0b/BBE COI in CPG development EN FINAL.pdf|CIHR/PHAC Best Brains Exchange (English) - Reducing and managing conflicts of interest in clinical practice guideline development: Do we need Pan-Canadian standards?]]
   −
[[Media:BBE COI in CPG development _FR_FINAL.pdf|Échanges Meilleurs Cerveaux IRSC/ASPC (français) - Réduction et gestion des conflits d’intérêts dans l’élaboration de recommandations pour la pratique clinique : faut-il établir des normes pancanadiennes?]]
+
[[Images/e/e1/BBE COI in CPG development FR FINAL.pdf|Échanges Meilleurs Cerveaux IRSC/ASPC (français) - Réduction et gestion des conflits d’intérêts dans l’élaboration de recommandations pour la pratique clinique : faut-il établir des normes pancanadiennes?]]
    
Shortly after the BBE, the Canadian Medical Association Journal, one of the foremost publishers of guidelines in Canada, announced that as of 2020, all groups publishing guidelines in their journal must adhere to the GIN principles.<ref>Kelsall D. New CMAJ policy on competing interests in guidelines. CMAJ. 2019; 191(13):E350-351. </ref> Therefore it is anticipated that a key area for national leadership in this area will be to help Canadian guideline producers (within PHAC or external) in adhering to the GIN principles, and generally implementing best practices related to COI. For some groups, this may require only small shifts in their current policies and procedures, while for other groups (e.g., smaller or with less resources) this could require considerable work.  
 
Shortly after the BBE, the Canadian Medical Association Journal, one of the foremost publishers of guidelines in Canada, announced that as of 2020, all groups publishing guidelines in their journal must adhere to the GIN principles.<ref>Kelsall D. New CMAJ policy on competing interests in guidelines. CMAJ. 2019; 191(13):E350-351. </ref> Therefore it is anticipated that a key area for national leadership in this area will be to help Canadian guideline producers (within PHAC or external) in adhering to the GIN principles, and generally implementing best practices related to COI. For some groups, this may require only small shifts in their current policies and procedures, while for other groups (e.g., smaller or with less resources) this could require considerable work.  
Line 27: Line 27:  
Diclosure of interests is the first step towards the proper management of any COIs that may be present. However, a common challenge among guideline developers is that disclosure forms often do not solicit sufficient detail to allow for a fulsome assessment for the presence of COI. In order to carry out an assessment, as described in the section below, we must rely on disclosure of information related to those factors. Figure 1 provides an overview of the link between disclosures and assessments of interests, and the identification and management of COI.[[File:COI processes.jpg|center|frame|622x622px|<u>Figure 1.</u> An overview of processes involved in the disclosure and assessment of interests, and identification and management of COI]]
 
Diclosure of interests is the first step towards the proper management of any COIs that may be present. However, a common challenge among guideline developers is that disclosure forms often do not solicit sufficient detail to allow for a fulsome assessment for the presence of COI. In order to carry out an assessment, as described in the section below, we must rely on disclosure of information related to those factors. Figure 1 provides an overview of the link between disclosures and assessments of interests, and the identification and management of COI.[[File:COI processes.jpg|center|frame|622x622px|<u>Figure 1.</u> An overview of processes involved in the disclosure and assessment of interests, and identification and management of COI]]
   −
Thus, PHAC has developed a disclosure of interest form that can be adapted by a wide variety of users, that solicits the details required to allow for an assessment to determine the presence of COI, as outlined in the following section. This disclosure form has been designed to be used in conjunction with the COI assessment tool provided below, but does not need to be. Groups may adopt the form as is, or adapt it to better suit the particular needs of their guideline development group.  
+
Thus, PHAC has developed a disclosure of interest form that can be adapted by a wide variety of users, that solicits the details required to allow for an assessment to determine the presence of COI, as outlined in the following section. This disclosure form has been designed to be used in conjunction with the COI assessment tool provided below, but does not need to be. Groups may adopt the form as is, or adapt it to better suit the particular needs of their guideline development group. Note that certain elements of the form (e.g., PHAC privacy notice statement) are specific to external advisory bodies that serve PHAC.  
   −
[[Media: PHAC_DOI_form_11Sept2020_v9.0.docx|Download PHAC Dislosure of Interest Form (last updated Sept 11, 2020)]]
+
[[Images/b/b2/PHAC DOI form 11Sept2020 v9.0.docx|Download PHAC Dislosure of Interest Form (last updated Sept 11, 2020)]]
    
== PHAC COI assessment tool for guideline development ==
 
== PHAC COI assessment tool for guideline development ==
Line 64: Line 64:       −
[[Media: PHAC_COI_Tool_19Aug2020.xlsx|Download PHAC COI Assessment Tool (last updated Aug 19, 2020)]]
+
[[Images/4/4d/PHAC COI Tool 19Aug2020.xlsx|Download PHAC COI Assessment Tool (last updated Aug 19, 2020)]]
    
== Guidelines International Network (GIN) checklist ==
 
== Guidelines International Network (GIN) checklist ==